Literature DB >> 30954732

Multiple Burr-Hole Surgery for the Treatment of Moyamoya Disease and Quasi-Moyamoya Disease in Children: Preliminary Surgical and Imaging Results.

Giuseppe Mirone1, Domenico Cicala2, Chiara Meucci3, Alessandra d'Amico4, Claudia Santoro5, Mario Muto6, Giuseppe Cinalli3.   

Abstract

OBJECTIVE: Moyamoya disease (MMD) is characterized by a progressive spontaneous occlusion of distal internal carotid arteries and its main branches. It is necessary to promptly diagnose and treat this condition, especially in children, because of the high risk of stroke and consequent severe disability. In this study, we examine the role of multiple burr-hole surgery (MBHS) in the treatment of pediatric patients with MMD and quasi-MMD and the role of perfusion magnetic resonance imaging (MRI) in the surgical indication and during follow-up.
METHODS: We reviewed preoperative, early postoperative, and late postoperative MRI perfusion and digital subtraction angiography images together with clinical and surgical outcomes in 10 children with MMD treated by MBHS.
RESULTS: Fourteen MBHS procedures (6 unilateral, 2 bilateral, and 2 single-setting bilateral) were performed in 10 children. Clinical and radiologic follow-up for all patients ranges from 16 months to 7 years. No ischemic events (transient ischemic attacks or stroke) occurred during the follow-up period. Postoperative digital subtraction angiography showed good revascularization around the burr-hole sites in all patients. The functional efficacy of the surgery was confirmed by dynamic susceptibility contrast perfusion MRI studies in 8 patients.
CONCLUSIONS: Our data underline the good rate of success of MBHS in pediatric MMD and quasi-MMD. This technique results in good collateral revascularization, improved cerebral perfusion and excellent short and long-term symptoms control, with low perioperative risk. Postoperative changes of perfusion parameters and ivy sign MRI finding seem to show a positive correlation and mainly occur in posterior middle cerebral artery territory.
Copyright © 2019. Published by Elsevier Inc.

Entities:  

Keywords:  Advent calendar technique; Indirect revascularization; Moyamoya disease; Multiple burr-hole technique; Neurofibromatosis; PWI MRI; Quasi-moyamoya disease

Mesh:

Year:  2019        PMID: 30954732     DOI: 10.1016/j.wneu.2019.03.282

Source DB:  PubMed          Journal:  World Neurosurg        ISSN: 1878-8750            Impact factor:   2.104


  3 in total

1.  Pediatric Moyamoya Disease and Syndrome in Italy: A Multicenter Cohort.

Authors:  Chiara Po'; Margherita Nosadini; Marialuisa Zedde; Rosario Pascarella; Giuseppe Mirone; Domenico Cicala; Anna Rosati; Alessandra Cosi; Irene Toldo; Raffaella Colombatti; Paola Martelli; Alessandro Iodice; Patrizia Accorsi; Lucio Giordano; Salvatore Savasta; Thomas Foiadelli; Giuseppina Sanfilippo; Elvis Lafe; Federico Zappoli Thyrion; Gabriele Polonara; Serena Campa; Federico Raviglione; Barbara Scelsa; Stefania Maria Bova; Filippo Greco; Duccio Maria Cordelli; Luigi Cirillo; Francesco Toni; Valentina Baro; Francesco Causin; Anna Chiara Frigo; Agnese Suppiej; Laura Sainati; Danila Azzolina; Manuela Agostini; Elisabetta Cesaroni; Luigi De Carlo; Gabriella Di Rosa; Giacomo Esposito; Luisa Grazian; Giovanna Morini; Francesco Nicita; Francesca Felicia Operto; Dario Pruna; Paola Ragazzi; Massimo Rollo; Alberto Spalice; Pasquale Striano; Aldo Skabar; Luigi Alberto Lanterna; Andrea Carai; Carlo Efisio Marras; Renzo Manara; Stefano Sartori
Journal:  Front Pediatr       Date:  2022-05-06       Impact factor: 3.418

2.  Acute ischemic stroke secondary to ventriculoperitoneal shunt dysfunction in a child with Moyamoya syndrome.

Authors:  Francesca Vitulli; Pietro Spennato; Domenico Cicala; Giuseppe Mirone; Maria Rosaria Scala; Giuseppe Cinalli
Journal:  Surg Neurol Int       Date:  2022-07-15

Review 3.  Progression in Moyamoya Disease: Clinical Features, Neuroimaging Evaluation, and Treatment.

Authors:  Xin Zhang; Weiping Xiao; Qing Zhang; Ding Xia; Peng Gao; Jiabin Su; Heng Yang; Xinjie Gao; Wei Ni; Yu Lei; Yuxiang Gu
Journal:  Curr Neuropharmacol       Date:  2022       Impact factor: 7.708

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.